Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

NCT06939452

Conditions: Adenocarcinoma, Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma, Carcinoma, +3 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Active, not recruiting

A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

NCT05808608

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Active, not recruiting

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

NCT04792073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations: Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States

View Trial Details

Active, not recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

NCT02673333

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, not recruiting

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

NCT05703269

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, Adult, +46 more
Locations: Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Crossroads Cancer Center Effingham, Illinois, United States

HSHS Saint Elizabeth's Hospital O'Fallon, Illinois, United States

View all 34 locations

View Trial Details

Active, not recruiting

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02845323

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: UCLA Institute of Urologic Oncology Los Angeles, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

University of Chicago Chicago, Illinois, United States

Johns Hopkins Hospital Baltimore, Maryland, United States

View Trial Details

Active, not recruiting

Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients

NCT03916627

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, not recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

NCT03737734

Conditions: Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +30 more
Locations: Davidof Cancer Institution at the Rabin Medical Center Israel Petah Tikva, Israel

View Trial Details

Active, not recruiting

The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

NCT04916808

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations: GenesisCare Alexandria, New South Wales, Australia

Royal Melbourne Hospital Parkville, Victoria, Australia

View Trial Details

Active, not recruiting

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

NCT06504615

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +18 more
Locations: Local Institution - 0001 Paris, France

Kappa Santé Paris, France

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions